Your search history is turned on.
Date: July 21, 2022 Jurisdictions: Alberta, British Columbia, Ontario
Claritas Pharmaceuticals, Inc. MATERIAL CHANGE REPORT Item 1: Name and Address of Company Claritas Pharmaceuticals, Inc. (the Company) 4040 Civic Center Drive Suite 200 San Rafael, California, USA, 94903 Item 2: Dates of Material Change July 19, 2022 Item 3: News Release News releases were issued and disseminated through the facilities of Executive Business ...
Claritas Announces Issuance of Failure-to-file Cease Trade Order by BCSC SAN FRANCISCO, CA -- (July 21, 2022) Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the "Company" or "Claritas") today announced that the British Columbia Securities Commission (the BCSC) has issued a Failure-to-File Cease Trade Order against the Company (the "FFCTO") on July 19...
Date: June 24, 2022 Jurisdictions: Alberta, British Columbia, Ontario
Claritas Provides Management Cease Trade Order & Corporate Update Per Policy Statement 12-203 SAN FRANCISCO, CA -- (JUNE 24, 2022) Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE (TSXV) symbol: CLAS and OTC symbol: CLAZF) (the "Company" or "Claritas") is providing an update with respect to its previously announced management cease trade order (MCTO) issued b...
Date: June 10, 2022 Jurisdictions: Alberta, British Columbia, Ontario
Claritas Provides Management Cease Trade Order & Corporate Update Per Policy Statement 12-203 SAN FRANCISCO, CA -- (JUNE 10, 2022) Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE (TSXV) symbol: CLAS and OTC symbol: CLAZF) (the "Company" or "Claritas") is providing an update with respect to its previously announced management cease trade order (MCTO) issued b...
Date: May 27, 2022 Jurisdictions: Alberta, British Columbia, Ontario
Claritas Pharmaceuticals, Inc. MATERIAL CHANGE REPORT Item 1: Name and Address of Company Claritas Pharmaceuticals, Inc. (the Company) 4040 Civic Center Drive Suite 200 San Rafael, California, USA, 94903 Item 2: Dates of Material Change May 27, 2022 Item 3: News Release News releases were issued and disseminated through the facilities of Executive Business Ser...
Claritas Provides Management Cease Trade Order & Corporate Update Per Policy Statement 12-203 SAN FRANCISCO, CA -- (MAY 27, 2022) Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE (TSXV) symbol: CLAS and OTC symbol: CLAZF) (the "Company" or "Claritas") is providing an update with respect to its previously announced management cease trade order (MCTO) issued by the Com...
Date: May 16, 2022 Jurisdictions: Alberta, British Columbia, Ontario
Claritas Pharmaceuticals, Inc. MATERIAL CHANGE REPORT Item 1: Name and Address of Company Claritas Pharmaceuticals, Inc. (the Company) 4040 Civic Center Drive Suite 200 San Rafael, California, USA, 94903 Item 2: Dates of Material Change May 4, 2022 Item 3: News Release News releases were issued and disseminated through the facilities of Executive Business Serv...
Date: May 13, 2022 Jurisdictions: Alberta, British Columbia, Ontario
Claritas Provides Management Cease Trade Order Update Per Policy Statement 12-203 SAN FRANCISCO, CA (MAY 13, 2022) Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE (TSXV) symbol: CLAS and OTC symbol: CLAZF) (the Company or Claritas) is providing an update with respect to its previously announced management cease trade order (MCTO) issued by the Companys princi...
Date: May 4, 2022 Jurisdictions: Alberta, British Columbia, Ontario
Claritas Announces Late Filing of Annual Documents and Management Cease Trade Order Affecting Management SAN FRANCISCO, CA -- (MAY 4, 2022) Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE (TSXV) symbol: CLAS and OTC symbol: CLAZF) (the "Company" or "Claritas") announced that further to its news release of April 29, 2022 the British Columbia Securities Commission (the ...
Date: April 30, 2021 Jurisdictions: Alberta, British Columbia, Ontario
Q4 2020 MDA_final 39161-2001 27553992.1 CLARITAS PHARMACEUTICALS, INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS As of April 28, 2021 For the year ended December 31, 2020 This management discussion and analysis (MD&A) of Claritas Pharmaceuticals, Inc. (the Company or Claritas) is for th...